Molecular mechanisms of colon cancer chemoprevention: Studies on the potential of intestinal fermentation products to induce glutathione S-transferases in colonic epithelium cells
Molecular mechanisms of colon cancer chemoprevention: Studies on the potential of intestinal fermentation products to induce glutathione S-transferases in colonic epithelium cells
批准号:
5391168
负责人:
Professor Dr. Michael Glei, since 7/2008
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2003
资助国家:
德国
项目状态:
已结题
起止时间:
2002-12-31 至 2010-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nutritional factors may enhance or prevent colorectal carcinogenesis retard the process. Some protective compounds, such as butyrate, are formed during gut flora fermentation of dietary fibre. In non-transformed cells, butyrate is utilised as an energy source. In transformed cells, it promotes apoptosis and differentiation, inhibits proliferation and induces glutathione S-transferase (GST) activity. GSTs are a superfamily of phase II enzymes that can detoxify cancer risk factors. We have shown that the genotoxic effects of 4-hydroxynonenal (HNE) a product of lipid oxidation, are decreased in cells which have been pretreated with butyrate and have increased levels of GSTP1. Preliminary findings show that GSTA4-4, which is highly specific for HNE, may also be inducible. In cells depleted of glutathione (GSH), HNE's genotoxicity is enhaced. Thus, the susceptibility of colon cells to this cancer risk factor depends on their capacity to conjugate with GSH. Consequently, nutritional intervention with highly fermentable dietary fibre could be protective by inducing GST's. Since, little is known about such mechanisms in non-transformed human colon cells, it is the aim of this proposal is to assess whether butyrate induces GST in non-tumor colon cells. Primary isolated colon cells will be treated with butyrate and the induction of GSTs and resistence forward risk factors, will be studied using a new methods of molecular biology. The results will provide first insights into as to whether this mechanism of chemoprotection could play a role in non-transformed human cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位: